This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Walker PD et al. (2007) Dense deposit disease is not a membranoproliferative glomerulonephritis. Mod Pathol 20: 605–616
Appel GB et al. (2005) Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16: 1392–1403
Braun MC et al. (2005) Recurrence of membranoproliferative glomerulonephritis type II in renal allografts: The North American Pediatric Renal Transplant Cooperative Study experience. J Am Soc Nephrol 16: 2225–2233
Lilford RJ et al. (1995) Clinical trials and rare diseases: a way out of a conundrum. BMJ 311: 1621–1625
Acknowledgements
The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Andrésdóttir, M. Recommendations for the diagnosis and treatment of dense deposit disease. Nat Rev Nephrol 4, 68–69 (2008). https://doi.org/10.1038/ncpneph0678
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0678
This article is cited by
-
Eculizumab in dense-deposit disease after renal transplantation
Pediatric Nephrology (2014)